The danger control concept in kidney disease: Mesangial cells

Journal of Nephrology

Volumn 26, Issue 3, 2013, Pages 437-449

  Migliorini, Adriana ^a   Ebid, Rainer ^a   Rebecca Scherbaum, Christina ^a   Anders, Hans Joachim ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Chronic kidney disease; Coagulation; Fibrosis; Glomerulonephritis; Glomerulosclerosis; Inflammation; Mesangium; Repair

Indexed keywords

BLEEDING; BLOOD CLOTTING; CELL DAMAGE; CELL REGENERATION; DIABETIC NEPHROPATHY; FIBRINOLYSIS; GENETIC CONSERVATION; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HEALING; HOMEOSTASIS; HUMAN; IMMUNE COMPLEX NEPHRITIS; INFECTION RISK; INFLAMMATION; KIDNEY AMYLOIDOSIS; KIDNEY DISEASE; KIDNEY EPITHELIUM; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; LIGHT CHAIN DEPOSITION DISEASE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM CELL; NONHUMAN; PODOCYTE; REVIEW; RISK REDUCTION; SCAR FORMATION; TISSUE REPAIR; ULTRASTRUCTURE;

GLOMERULONEPHRITIS; HOMEOSTASIS; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MESANGIAL CELLS; UROTHELIUM;

EID: 84877941083     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000247     Document Type: Review

References (134)

1. Pricam C, Humbert F, Perrelet A, Orci L. Gap junctions in mesangial and lacis cells. J Cell Biol. 1974;63(1): 349-354.
2. Díaz-Flores L, Gutiérrez R, Madrid JF, et al. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol. 2009; 24(7):909-969.
3. Schlondorff D. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J. 1987;1(4):272-281.
4. Herrera GA, Turbat-Herrera EA, Teng J. Mesangial homeostasis and pathobiology: their role in health and disease. Contrib Nephrol. 2011;169:6-22.
5. Soos TJ, Sims TN, Barisoni L, et al. CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int. 2006;70(3):591-596.
6. Segerer S, Heller F, Lindenmeyer MT, et al. Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int. 2008;74(1):37-46.
7. Vielhauer V, Schwarz M, Taubitz A. Characterization of glomerular dendritic cells by flow cytometry [abstract]. J Am Soc Nephrol. 2009;20:558A.
8. Miner JH. Renal basement membrane components. Kidney Int. 1999;56(6):2016-2024.
9. Kriz W, Elger M, Lemley KV, Sakai T. Mesangial cell-glomerular basement membrane connections counteract glomerular capillary and mesangium expansion. Am J Nephrol. 1990;10 (Suppl 1):4-13.
10. Borza CM, Pozzi A. The role of cell-extracellular matrix interactions in glomerular injury. Exp Cell Res. 2012;318(9): 1001-1010.
11. Schreiner GF. The mesangial phagocyte and its regulation of contractile cell biology. J Am Soc Nephrol. 1992;2(10) (Suppl):S74-S82.
12. Nichols SA, Dirks W, Pearse JS, King N. Early evolution of animal cell signaling and adhesion genes. Proc Natl Acad Sci USA. 2006;103(33):12451-12456.
13. Schilmiller AL, Howe GA. Systemic signaling in the wound response. Curr Opin Plant Biol. 2005;8(4):369-377.
14. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(7193):314-321.
15. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341(10):738-746.
16. Clark RA. Cutaneous tissue repair: Part I: basic biologic considerations. J Am Acad Dermatol. 1985;13(5 Pt 1):701-725.
17. Martin P. Wound healing: aiming for perfect skin regeneration. Science. 1997;276(5309):75-81.
18. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(Suppl 1):S13-S33.
19. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428-435.
20. Messier-Solek C, Buckley KM, Rast JP. Highly diversified innate receptor systems and new forms of animal immunity. Semin Immunol. 2010;22(1):39-47.
21. Gauthier ME, Du Pasquier L, Degnan BM. The genome of the sponge Amphimedon queenslandica provides new perspectives into the origin of Toll-like and interleukin 1 receptor pathways. Evol Dev. 2010;12(5):519-533.
22. Wiens M, Korzhev M, Perovic-Ottstadt S, et al. Toll-like receptors are part of the innate immune defense system of sponges (demospongiae: Porifera). Mol Biol Evol. 2007;24(3):792-804.
23. Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annu Rev Immunol. 2010;28:321-342.
24. Anders HJ. Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol. 2010;21(8):1270-1274.
25. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol. 2011;11(4):264-274.
26. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis of sepsis. Annu Rev Pathol. 2011;6(1):19-48.
27. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835-870.
28. Appel D, Kershaw DB, Smeets B, et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol. 2009;20(2):333-343.
29. Ronconi E, Sagrinati C, Angelotti ML, et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol. 2009;20(2):322-332.
30. Sopova K, Tatsidou P, Stellos K. Platelets and platelet interaction with progenitor cells in vascular homeostasis and inflammation. Curr Vasc Pharmacol. 2012;10(5):555-562.
31. Zenewicz LA, Flavell RA. Recent advances in IL-22 biology. Int Immunol. 2011;23(3):159-163.
32. Sugawara T, Gallucci RM, Simeonova PP, Luster MI. Regulation and role of interleukin 6 in wounded human epithelial keratinocytes. Cytokine. 2001;15(6):328-336.
33. Pickert G, Neufert C, Leppkes M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med. 2009;206(7):1465-1472.
34. Nishida T, Nakamura M, Mishima H, Otori T. Interleukin 6 promotes epithelial migration by a fibronectin-dependent mechanism. J Cell Physiol. 1992;153(1):1-5.
35. Mizoguchi A. Healing of intestinal inflammation by IL-22. Inflamm Bowel Dis. 2012;18(9):1777-1784.
36. Jiang GX, Zhong XY, Cui YF, et al. IL-6/STAT3/TFF3 signaling regulates human biliary epithelial cell migration and wound healing in vitro. Mol Biol Rep. 2010;37(8):3813-3818.
37. Braun RK, Ferrick C, Neubauer P, et al. IL-17 producing gamma delta T cells are required for a controlled inflammatory response after bleomycin-induced lung injury. Inflammation. 2008;31(3):167-179.
38. Ryu M, Migliorini A, Miosge N, et al. Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury. J Pathol. In press.
39. Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol. 2010;21(11):1819-1834.
40. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol. 2010;21(2): 212-222.
41. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112(12): 1776-1784.
42. Niedermeier M, Reich B, Rodriguez Gomez M, et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci USA. 2009;106(42): 17892-17897.
43. Humphreys BD, Lin SL, Kobayashi A, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol. 2010;176(1):85-97.
44. Sörensen I, Susnik N, Inhester T, et al. Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis. Kidney Int. 2011;80(10):1035-1044.
45. Drew AF, Tucker HL, Liu H, Witte DP, Degen JL, Tipping PG. Crescentic glomerulonephritis is diminished in fibrinogendeficient mice. Am J Physiol Renal Physiol. 2001;281(6): F1157-F1163.
46. Wiggins RC, Njoku N, Sedor JR. Tissue factor production by cultured rat mesangial cells: stimulation by TNF alpha and lipopolysaccharide. Kidney Int. 1990;37(5):1281-1285.
47. Villamediana LM, Rondeau E, He CJ, et al. Thrombin regulates components of the fibrinolytic system in human mesangial cells. Kidney Int. 1990;38(5):956-961.
48. Yang AH, Chang HJ. Effect of fibrin matrix on growth of glomerular cells. Am J Pathol. 1992;140(3):569-579.
49. Meulders Q, He CJ, Adida C, et al. Tumor necrosis factor alpha increases antifibrinolytic activity of cultured human mesangial cells. Kidney Int. 1992;42(2):327-334.
50. Yamabe H, Osawa H, Inuma H, et al. Tissue factor pathway inhibitor production by human mesangial cells in culture. Thromb Haemost. 1996;76(2):215-219.
51. Liu N, Ono T, Suyama K, et al. Mesangial factor V expression colocalized with fibrin deposition in IgA nephropathy. Kidney Int. 2000;58(2):598-606.
52. Hertig A, Rondeau E. Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury. J Am Soc Nephrol. 2004;15(4):844-853.
53. Anders HJ, Vielhauer V, Kretzler M, et al. Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J Am Soc Nephrol. 2001;12(5):919-931.
54. Gómez-Guerrero C, Suzuki Y, Egido J. The identification of IgA receptors in human mesangial cells: in the search for "Eldorado". Kidney Int. 2002;62(2):715-717.
55. Pickering M, Cook HT. Complement and glomerular disease: new insights. Curr Opin Nephrol Hypertens. 2011;20(3): 271-277.
56. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: a new look at an old entity. N Engl J Med. 2012; 366(12):1119-1131.
57. Brandt J, Pippin J, Schulze M, et al. Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int. 1996; 49(2):335-343.
58. Johnson RJ, Raines EW, Floege J, et al. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med. 1992;175(5):1413-1416.
59. Hugo C, Shankland SJ, Bowen-Pope DF, Couser WG, Johnson RJ. Extraglomerular origin of the mesangial cell after injury: a new role of the juxtaglomerular apparatus. J Clin Invest. 1997;100(4):786-794.
60. Imasawa T, Utsunomiya Y, Kawamura T, et al. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol. 2001;12(7): 1401-1409.
61. Kunter U, Rong S, Djuric Z, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol. 2006;17(8): 2202-2212.
62. Anders HJ. Innate pathogen recognition in the kidney: tolllike receptors, NOD-like receptors, and RIG-like helicases. Kidney Int. 2007;72(9):1051-1056.
63. Patole PS, Pawar RD, Lech M, et al. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol Dial Transplant. 2006;21(11):3062-3073.
64. Patole PS, Gröne HJ, Segerer S, et al. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol. 2005;16(5):1326-1338.
65. Pawar RD, Castrezana-Lopez L, Allam R, et al. Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier. Immunology. 2009;128(1)(Suppl):e206-e221.
66. Wörnle M, Schmid H, Banas B, et al. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol. 2006;168(2):370-385.
67. Merkle M, Ribeiro A, Wörnle M. TLR3-dependent regulation of cytokines in human mesangial cells: a novel role for IP-10 and TNF-alpha in hepatitis C-associated glomerulonephritis. Am J Physiol Renal Physiol. 2011;301(1): F57-F69.
68. Lichtnekert J, Vielhauer V, Zecher D, et al. Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif. Am J Physiol Renal Physiol. 2009;296(4):F867-F874.
69. Brown HJ, Lock HR, Sacks SH, Robson MG. TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J Immunol. 2006;177(3):1925-1931.
70. Brown HJ, Lock HR, Wolfs TG, Buurman WA, Sacks SH, Robson MG. Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol. 2007;18(6):1732-1739.
71. Anders HJ, Banas B, Linde Y, et al. Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors. J Am Soc Nephrol. 2003;14(2):317-326.
72. Anders HJ, Vielhauer V, Eis V, et al. Activation of toll-like receptor-9 induces progression of renal disease in MRLFas(lpr) mice. FASEB J. 2004;18(3):534-536.
73. Pawar RD, Patole PS, Zecher D, et al. Toll-like receptor-7 modulates immune complex glomerulonephritis. J Am Soc Nephrol. 2006;17(1):141-149.
74. Pawar RD, Ramanjaneyulu A, Kulkarni OP, Lech M, Segerer S, Anders HJ. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol. 2007;18(6): 1721-1731.
75. Patole PS, Zecher D, Pawar RD, Gröne HJ, Schlöndorff D, Anders HJ. G-rich DNA suppresses systemic lupus. J Am Soc Nephrol. 2005;16(11):3273-3280.
76. Pawar RD, Patole PS, Wörnle M, Anders HJ. Microbial nucleic acids pay a Toll in kidney disease. Am J Physiol Renal Physiol. 2006;291(3):F509-F516.
77. Patole PS, Pawar RD, Lichtnekert J, et al. Coactivation of Toll-like receptor-3 and-7 in immune complex glomerulonephritis. J Autoimmun. 2007;29(1):52-59.
78. Anders HJ, Banas B, Schlöndorff D. Signaling danger: tolllike receptors and their potential roles in kidney disease. J Am Soc Nephrol. 2004;15(4):854-867.
79. Anders HJ, Frink M, Linde Y, et al. CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol. 2003;170(11):5658-5666.
80. Anders HJ, Ninichuk V, Schlöndorff D. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int. 2006;69(1): 29-32.
81. Anders HJ, Vielhauer V, Schlöndorff D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int. 2003;63(2):401-415.
82. Ninichuk V, Clauss S, Kulkarni O, et al. Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice. Am J Pathol. 2008;172(3):628-637.
83. Wolf G, Bohlender J, Bondeva T, Roger T, Thaiss F, Wenzel UO. Angiotensin II upregulates toll-like receptor 4 on mesangial cells. J Am Soc Nephrol. 2006;17(6):1585-1593.
84. Bondeva T, Roger T, Wolf G. Differential regulation of Tolllike receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites. Am J Nephrol. 2007;27(3):308-314.
85. Wornle M, Roeder M, Sauter M, Merkle M, Ribeiro A. Effect of dsRNA on mesangial cell synthesis of plasminogen activator inhibitor type 1 and tissue plasminogen activator. Nephron, Exp Nephrol. 2009;113(2):e57-e65.
86. Merkle M, Ribeiro A, Köppel S, et al. TLR3-dependent immune regulatory functions of human mesangial cells. Cell Mol Immunol. 2012;9(4):334-340.
87. Krötz F. TNF receptor subtype 2 induction by viral dsRNA involves IP-10 and TNF-alpha in glomerular mesangial inflammation. Am J Physiol Renal Physiol. 2011;301(1):F55-F56.
88. Flür K, Allam R, Zecher D, et al. Viral RNA induces type I interferon-dependent cytokine release and cell death in mesangial cells via melanoma-differentiation-associated gene-5: Implications for viral infection-associated glomerulonephritis. Am J Pathol. 2009;175(5):2014-2022.
89. Anders HJ, Lichtnekert J, Allam R. Interferon-alpha and-beta in kidney inflammation. Kidney Int. 2010;77(10): 848-854.
90. Allam R, Lichtnekert J, Moll A, Taubitz A, Vielhauer V, Anders HJ. Viral RNA and DNA sense common antiviral responses including type i interferons in mesangial cells. J Am Soc Nephrol. 2009;20:1986-1996.
91. Hägele H, Allam R, Pawar RD, Anders HJ. Double-stranded RNA activates type I interferon secretion in glomerular endothelial cells via retinoic acid-inducible gene (RIG)-1. Nephrol Dial Transplant. 2009;24(11):3312-3318.
92. Hägele H, Allam R, Pawar RD, Reichel CA, Krombach F, Anders HJ. Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway. Am J Pathol. 2009;175(5):1896-1904.
93. Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6): 821-832.
94. Anders HJ, Muruve DA. The inflammasomes in kidney disease. J Am Soc Nephrol. 2011;22(6):1007-1018.
95. Vilaysane A, Chun J, Seamone ME, et al. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol. 2010;21(10):1732-1744.
96. Lichtnekert J, Kulkarni OP, Mulay SR, et al. Anti-GBM glomerulonephritis involves IL-1 but is independent of NLRP3/ASC inflammasome-mediated activation of caspase-1. PLoS ONE. 2011;6(10):e26778.
97. Vielhauer V, Anders HJ, Schlöndorff D. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis. Semin Nephrol. 2007;27(1):81-97.
98. Vielhauer V, Kulkarni O, Reichel CA, Anders HJ. Targeting the recruitment of monocytes and macrophages in renal disease. Semin Nephrol. 2010;30(3):318-333.
99. Anders HJ, Ryu M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int. 2011;80(9):915-925.
100. Lu C, He JC, Cai W, Liu H, Zhu L, Vlassara H. Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proc Natl Acad Sci USA. 2004;101(32):11767-11772.
101. Duffy JL, Churg J. Extracellular fibrils in the renal glomerulus. Ultrastruct Pathol. 1984;6(4):iii-vi.
102. Keeling J, Herrera GA. The mesangium as a target for glomerulopathic light and heavy chains: pathogenic considerations in light and heavy chain-mediated glomerular damage. Contrib Nephrol. 2007;153:116-134.
103. Keeling J, Herrera GA. An in vitro model of light chain deposition disease. Kidney Int. 2009;75(6):634-645.
104. Eremina V, Cui S, Gerber H, et al. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol. 2006;17(3):724-735.
105. Lindahl P, Hellström M, Kalén M, et al. Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development. 1998;125(17):3313-3322.
106. Floege J, Eitner F, Alpers CE. A new look at plateletderived growth factor in renal disease. J Am Soc Nephrol. 2008;19(1):12-23.
107. Kaukinen A, Kuusniemi AM, Helin H, Jalanko H. Changes in glomerular mesangium in kidneys with congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol. 2010;25(5):867-875.
108. Lasagni L, Ballerini L, Angelotti ML, et al. Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells. 2010;28(9):1674-1685.
109. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006;69(12): 2131-2147.
110. Sayyed SG, Hägele H, Kulkarni OP, et al. Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia. 2009;52(11):2445-2454.
111. Darisipudi MN, Kulkarni OP, Sayyed SG, et al. Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. Am J Pathol. 2011;179(1):116-124.
112. Kriz W, Lemley KV. The role of the podocyte in glomerulosclerosis. Curr Opin Nephrol Hypertens. 1999;8(4):489-497.
113. Teixeira VP, Blattner SM, Li M, et al. Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int. 2005;67(2):514-523.
114. Ryu M, Mulay SR, Miosge N, Gross O, Anders HJ. Tumour necrosis factor-nndrives Alport glomerulosclerosis in mice by promoting podocyte apoptosis. J Pathol. 2012;226(1): 120-131.
115. Ryu M, Kulkarni OP, Radomska E, Miosge N, Gross O, Anders HJ. Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-t-mediated podocyte loss. Kidney Int. 2011;79(2):189-198.
116. Ramirez-Carrozzi V, Sambandam A, Luis E, et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol. 2011;12(12):1159-1166.
117. Siironen J, Sandberg M, Vuorinen V, Röyttä M. Laminin B1 and collagen type IV gene expression in transected peripheral nerve: reinnervation compared to denervation. J Neurochem. 1992;59(6):2184-2192.
118. Siironen J, Sandberg M, Vuorinen V, Röyttä M. Expression of type I and III collagens and fibronectin after transection of rat sciatic nerve: reinnervation compared with denervation. Lab Invest. 1992;67(1):80-87.
119. Schrimpf C, Xin C, Campanholle G, et al. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol. 2012;23(5):868-883.
120. Wharram BL, Goyal M, Wiggins JE, et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol. 2005;16(10): 2941-2952.
121. Nso Roca AP, Peña Carrión A, Benito Gutiérrez M, García Meseguer C, García Pose A, Navarro M. Evolutive study of children with diffuse mesangial sclerosis. Pediatr Nephrol. 2009;24(5):1013-1019.
122. Gbadegesin R, Hinkes BG, Hoskins BE, et al. Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS). Nephrol Dial Transplant. 2008;23(4):1291-1297.
123. Roselli S, Heidet L, Sich M, et al. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol. 2004;24(2):550-560.
124. Blantz RC. Glomerular blood flow. Semin Nephrol. 1993; 13(5):436-446.
125. Oite T, Yao J. Disturbances of glomerular hemodynamics: a risk factor determing progression of glomerular diseases? J Nephrol. 2009;22(2):196-202.
126. Fogo AB. Mesangial matrix modulation and glomerulosclerosis. Exp Nephrol. 1999;7(2):147-159.
127. Abboud HE. Growth factors and the mesangium. J Am Soc Nephrol. 1992;2(10)(Suppl):S185-S189.
128. Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis. 2002;39(1):1-11.
129. Haralson MA, DiMari SJ, Hoover RL, Harris RC. Effects of epidermal growth factor on collagen expression by rat kidney mesangial cells in culture. Matrix Biol. 2000;19(1): 47-59.
130. Smeets B, Kuppe C, Sicking EM, et al. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol. 2011;22(7):1262-1274.
131. Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol. 2012;8(5):293-300.
132. Fioretto P, Mauer M. Reversal of diabetic nephropathy: lessons from pancreas transplantation. J Nephrol. 2012;25(1): 13-18.
133. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339(2):69-75.
134. Ruggenenti P, Perticucci E, Cravedi P, et al. Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol. 2008;19(6):1213-1224.